Evaluation of Parotid Gland Function using Equivalent Cross-relaxation Rate Imaging Applied Magnetization Transfer Effect
Safe imaging modalities are needed for evaluating parotid gland function. The aim of this study was to validate the utility of a magnetic resonance imaging (MRI) tool, equivalent cross-relaxation rate imaging (ECRI), as a measurement of parotid gland function after chemoradiotherapy. Subjects compri...
Saved in:
Published in | JOURNAL OF RADIATION RESEARCH Vol. 53; no. 1; pp. 138 - 144 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
THE JAPAN RADIATION RESEARCH SOCIETY
01.01.2012
The Japan Radiation Research Society and Japanese Society for Therapeutic Radiology and Oncology Oxford University Press |
Subjects | |
Online Access | Get full text |
ISSN | 0449-3060 1349-9157 1349-9157 |
DOI | 10.1269/jrr.11059 |
Cover
Summary: | Safe imaging modalities are needed for evaluating parotid gland function. The aim of this study was to validate the utility of a magnetic resonance imaging (MRI) tool, equivalent cross-relaxation rate imaging (ECRI), as a measurement of parotid gland function after chemoradiotherapy. Subjects comprised 18 patients with head-neck cancer who underwent ECRI and salivary gland scintigraphy. First, we calculated ECR values (signal intensity on ECRI), maximum uptake rate (MUR) and washout rate (WOR) from salivary gland scintigraphy data at the parotid glands. Second, we investigated correlations between ECR values and each parameter of MUR (uptake function) and WOR (secretory function) obtained by salivary gland scintigraphy at the parotid gland. Next, we investigated each dose-response for ECR, MUR and WOR at the parotid gland. A correlation was detected between ECR values and MUR in both the pre- (r=-0.55, p<0.01) and post-treatment (r=-0.50, p<0.05) groups. A significant post-treatment correlation was detected between the percentage change in ECR values at 3-5 months after chemoradiotherapy and median dose to the parotid gland (Pearson correlation, r=-0.62, p<0.05). However, no correlations were detected between median dose to the parotid gland and either MUR or WOR. ECRI is a new imaging tool for evaluating the uptake function of the parotid gland after chemoradiotherapy. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ISSN: | 0449-3060 1349-9157 1349-9157 |
DOI: | 10.1269/jrr.11059 |